Grant H. Skrepnek, Ph.D., R.Ph.

Professor

Pharmacy Clinical & Admin Sci

Phone (405) 271-6878 x47105

Fax (4050 271-6430

Office CPB 214

Email grant-skrepnek@ouhsc.edu


Summary

I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.



Research

Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.




Education & Experience

Ph.D. in Pharmacy Administration

University of Texas at Austin, Austin, TX

Dissertation: Stock market valuation and firm-level determinants of innovative activity in the pharmaceutical industry.


2002

M.S. in Pharmacy Administration

University of Texas at Austin, Austin, TX

Thesis: The effect of merger and acquisition activity on shareholder returns in the pharmaceutical industry.


1998

B.S. in Pharmacy Business Management

University of Texas at Austin, Austin, TX

1994


Publications & Presentations

1 2 3 4 > >>
    1. Schwier N C, Tran N T, Skrepnek G H. Clinical and economic outcomes associated with hospitalizations for acute idiopathic pericarditis in the United States. Heart & Lung. 2021; 50 : 825-31

    2. Dickson M C, Nguyen M M, Skrepnek G H. Diabetic supply utilization among Oklahoma Medicaid members [Legislative Report]. Oklahoma Health Care Authority. 2021

    3. Nguyen M, Dickson M C, Skrepnek G H. Medicaid Value-Based Contract (VBC) in partial-onset seizure disorder [Legislative Report]. Oklahoma Health Care Authority. 2021

    4. Nguyen M M, Dickson M C, Skrepnek G H. Medicaid Value-Based Contract (VBC) in primary generalized tonic-clonic seizures and involving adjunctive agents for the treatment of partial-onset seizures [Legislative Report]. Oklahoma Health Care Authority. 2021

    5. Dickson M C, Nguyen M M, Skrepnek G H. Medicaid Value-Based Contract (VBC) in the prevention of migraine [Legislative Report]. Oklahoma Health Care Authority. 2021

1 2 3 4 > >>



Grants

1 2 3 >>
    1. HIV Adherence Services. Start Date: 2022. End Date: 2023.

    2. Patterns of Care, Outcomes, and Barriers to Treatment Success or Vaccination Associated with Adult Community-Acquired Pneumonia in Medicaid. Misc Non-Federal. Start Date: 2021. End Date: 2022.

    3. [Service Agreement] Opioid Use Under Oklahoma Senate Bill 848.. Non-federal. Start Date: 2020. End Date: 2020.

    4. C1097002 - Improving evidence-based antibiotic use for treatment of infections commonly seen in long term . Federal Non-NIH. Start Date: 2019. End Date: 2020.

    5. C2010628 - Drug Utilization Review 2020 [Service Award]. State Agency. Start Date: 2019. End Date: 2020.

1 2 3 >>



Awards and Honors

>>
    >>



    Education


    no results